Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 1,276,355
- Share change
- -2,426,990
- Total reported value
- $717,889
- Price per share
- $0.56
- Number of holders
- 20
- Value change
- -$1,585,759
- Number of buys
- 6
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 21077P108?
CUSIP 21077P108 identifies CNTX - Context Therapeutics Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21077P108:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
1.2%
|
1,143,745
|
$745,379 | — | 31 Dec 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.96%
|
883,654
|
$583,653 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.7%
|
640,863
|
$417,650 | — | 31 Dec 2022 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.31%
|
281,889
|
$186,188 | — | 31 Dec 2022 | |
| swisspartners Ltd. |
13F
|
Company |
0.2%
|
180,000
|
$118,896 | — | 31 Dec 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
125,852
|
$82,000 | — | 31 Dec 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
105,809
|
$69,887 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.11%
|
105,300
|
$69,000 | — | 31 Dec 2022 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$68,188 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
61,202
|
$40,000 | — | 31 Dec 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.06%
|
57,455
|
$38,000 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
37,219
|
$24,256 | — | 31 Dec 2022 | |
| DIFESA CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.04%
|
34,878
|
$22,730 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
32,907
|
$21,735 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
26,534
|
$17,292 | — | 31 Dec 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
19,827
|
$12,921 | — | 31 Dec 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
19,350
|
$12,610 | — | 31 Dec 2022 | |
| Tarek Sahmoud |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$8,415 | — | 16 Aug 2022 | |
| Aspire Wealth Management Corp |
13F
|
Company |
0.01%
|
10,000
|
$6,517 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
8,857
|
$6,000 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,755
|
$1,791 | — | 31 Dec 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
400
|
$261 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
117
|
$76 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
101
|
$66 | — | 31 Dec 2022 | |
| Evan G. Dick |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
29,223
|
— | — | 15 Feb 2022 | |
| William F. Rencher |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
8,000
|
— | — | 15 Feb 2022 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q1 2023
As of 31 Mar 2023,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,276,355 shares.
The largest 10 holders included
VANGUARD GROUP INC, HighTower Advisors, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Mill Creek Capital Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, Virtu Financial LLC, NORTHERN TRUST CORP, DIFESA CAPITAL MANAGEMENT, LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
23
Q1 2023 holders
20
Holder diff
-3
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.